Based on 6 analysts giving stock ratings to Fresenius Medical Care AG in the past month.
In the current month, FMS has received 1 Buy Ratings, 1 Hold Ratings, and 3 Sell Ratings. FMS average Analyst price target in the last month is 24.913.
Based on analysts' estimates, FMS EPS is projected to reach 0.574 in FY2026Q3, following reported EPS of 0.473 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.47, while Fresenius Medical Care AGFMS's earnings per share (EPS) for the previous quarter was USD 0.25. EPS for the next quarter is expected at USD 0.57.